Patents by Inventor Carmen Cuevas

Carmen Cuevas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTITUMORAL COMPOUNDS
    Publication number: 20150342972
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Application
    Filed: August 12, 2015
    Publication date: December 3, 2015
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-lbarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • ANTITUMORAL COMPOUNDS
    Publication number: 20150344454
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Application
    Filed: August 12, 2015
    Publication date: December 3, 2015
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-lbarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • Antitumoral compounds
    Patent number: 9187445
    Abstract: A compound of general formula (I) wherein A, Y, W, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: November 17, 2015
    Assignee: PHARMA MAR, S.A.
    Inventors: Alberto Rodríguez Vicente, María Garranzo García-Ibarrola, Carmen Murcia Pérez, Francisco Sánchez Sancho, María del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digón Juárez
  • Anticancer steroidal lactones unsaturated in position 7 (8)
    Patent number: 8962602
    Abstract: A compound of general formula (I), wherein R1-R17 and the - - - - - - line take various meanings for use in the treatment of cancer.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: February 24, 2015
    Assignee: Pharma Mar, S.A.
    Inventors: Rogelio Fernández Rodríguez, José Fernando Reyes Benítez, Andrés Francesch Solloso, María del Carmen Cuevas Marchante
  • Antitumoral compounds
    Patent number: 8748388
    Abstract: Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof useful as antitumour agents.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: June 10, 2014
    Assignee: Pharma Mar, S.A.
    Inventors: Judit Tulla-Puche, Eleonora Marcucci, Núria Bayó-Puxan, Fernando Albericio, Maria del Carmen Cuevas Marchante
  • Antitumoral compounds
    Patent number: 8710264
    Abstract: A compound of general formula (I) wherein, R11, R12, R13, R14, R15, W, Y, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: April 29, 2014
    Assignee: Pharma Mar, S.A.
    Inventors: Alberto Rodríguez Vicente, Maria Garranzo García-Ibarrola, Carmen Murcia Pérez, Francisco Sánchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digón Juárez
  • Antitumoral dihydropyran-2-one compounds
    Patent number: 8501968
    Abstract: Antitumoral compounds obtained from a porifera, of the family Raspailiidae, genus Lithoplocamia, species lithistoides, and derivatives thereof are provided.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: August 6, 2013
    Assignee: PharmaMar, S.A.
    Inventors: Ma Jesús Martin López, Laura Coello Molinero, José Fernando Reyes Benítez, Alberto Rodríguez Vicente, María Garranzo García-Ibarrola, Carmen Murcia Pérez, Andrés Francesch Solloso, Francisco Sánchez Sancho, Maria del Carmen Cuevas Marchante, Rogelio Fernández Rodríguez
  • Synthetic Process for the Manufacture of Ecteinascidin Compounds
    Publication number: 20130066067
    Abstract: This invention relates to compounds of formula II: wherein R1, R2, ProtSH, and ProtNH are as defined, to processes for the synthesis of ecteinascidins of formula I from compounds of formula II, and to processes for the synthesis of compounds of formula II.
    Type: Application
    Filed: May 24, 2011
    Publication date: March 14, 2013
    Applicant: Pharma Mar, S.A.
    Inventors: Ma Jesús Martín López, Andrés Francesch Solloso, Maria del Carmen Cuevas Marchante
  • ANTICANCER STEROIDAL LACTONES UNSATURATED IN POSITION 7 (8)
    Publication number: 20130040921
    Abstract: A compound of general formula (I), wherein R1-R17 and the ------ line take various meanings for use in the treatment of cancer.
    Type: Application
    Filed: April 26, 2011
    Publication date: February 14, 2013
    Applicant: PHARMA MAR, S.A.
    Inventors: Rogelio Fernández Rodríguez, José Fernando Reyes Benítez, Andrés Francesch Solloso, María del Carmen Cuevas Marchante
  • Antitumoral dihydropyran-2-one compounds
    Patent number: 8324406
    Abstract: Antitumoral compounds obtained from a porifera, of the family Raspailiidae, genus Lithoplocamia, species lithistoides, and derivatives thereof are provided.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: December 4, 2012
    Assignee: Pharma Mar, S.A.
    Inventors: Ma Jesús Martín López, Laura Coello Molinero, José Fernando Reyes Benítez, Alberto Rodríguez Vicente, María Garranzo García-Ibarrola, Carmen Murcia Pérez, Andrés Francesch Solloso, Francisco Sánchez Sancho, María del Carmen Cuevas Marchante, Rogelio Fernández Rodríguez
  • ANTITUMORAL DIHYDROPYRAN-2-ONE COMPOUNDS
    Publication number: 20120190870
    Abstract: Antitumoral compounds obtained from a porifera, of the family Raspailiidae, genus Lithoplocamia, species lithistoides, and derivatives thereof are provided.
    Type: Application
    Filed: June 29, 2011
    Publication date: July 26, 2012
    Inventors: Ma Jesús Martín López, Laura Coello Molinero, José Fernando Reyes Benítez, Alberto Rodríguez Vicente, María Garranzo García- Ibarrola, Carmen Murcia Pérez, Andrés Francesch Solloso, Francisco Sánchez Sancho, María del Carmen Cuevas Marchante, Rogelio Fernández Rodríguez
  • ANTITUMORAL COMPOUNDS
    Publication number: 20120041063
    Abstract: A compound of general formula (I) wherein, R11, R12, R13, R14, R15, W, Y, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
    Type: Application
    Filed: December 19, 2008
    Publication date: February 16, 2012
    Applicant: PHARMA MAR, S.A.
    Inventors: Alberto Rodriguez Vicente, Maria Garranzo Garcia- Ibarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • Antitumoral derivatives of ET-743
    Patent number: 8076337
    Abstract: Derivatives of Et-743 or Et-770 or Et-729 are provided. The derivatives are of the general formula Ia.: wherein the substituent groups take various permitted meanings.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: December 13, 2011
    Assignee: Pharma Mar, S.A.
    Inventors: Valentin Martinez, Maria Flores, Pilar Gallego, Carmen Cuevas, Simon Munt, Ignacio Manzanares
  • Anticancer Compounds
    Publication number: 20110237520
    Abstract: Compounds of general formula I: wherein R1-R15 and n take permitted meanings for use in the treatment of cancer.
    Type: Application
    Filed: December 18, 2009
    Publication date: September 29, 2011
    Applicant: Pharma Mar, SA
    Inventors: Laura Coello Molinero, Rogelio Fernández Rodriguez, José Fernando Reyes Benitez, Andrés Francesch Solloso, Maria del Carmen Cuevas Marchante
  • Antitumoral analogs of ET-743
    Patent number: 8012975
    Abstract: Antitumor compounds have the five membered fused ring ecteinascidin structure of the formula (XIV). The present compounds lack a 1,4-bridging group as found in the ecteinascidins. They have at the C-1 position a substituent selected from an optionally protected or derivatised aminomethylene group or an optionally protected or derivatised hydroxymethylene group.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: September 6, 2011
    Assignee: Pharma Mar, S.A.
    Inventors: Ignacio Manzanares, Carmen Cuevas, Marta Perez, Maria Jesus Martin, Alberto Rodriguez, Simon Munt
  • ANTITUMORAL COMPOUNDS
    Publication number: 20110207674
    Abstract: Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof useful as antitumour agents.
    Type: Application
    Filed: December 10, 2008
    Publication date: August 25, 2011
    Applicant: PHARMA MAR, S.A.
    Inventors: Judit TULLA-PUCHE, Eleonora MARCUCCI, Núria BAYÓ-PUXAN, Fernando ALBERICIO, María del Carmen CUEVAS MARCHANTE
  • Synthesis of naturally occuring ecteinascidins and related compounds
    Patent number: 7947671
    Abstract: Ecteinascidin compounds with a quinone ring for ring E are active as anti-cancer agents. Related processes and compounds are provided.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: May 24, 2011
    Assignee: Pharma Mar, S.A.
    Inventors: Valentin Martinez Barrasa, Pilar Gallego, Carmen Cuevas, Simon Munt, Ignacio Manzanares, Roberto Menchaca, Natividad Rodriguez, Alberto Rodriguez
  • Antitumoral Macrolides
    Publication number: 20110118343
    Abstract: Antitumoral compounds of general formula I: wherein R1-R14 and the lines take permitted meanings for use in the treatment of cancer.
    Type: Application
    Filed: July 2, 2009
    Publication date: May 19, 2011
    Applicant: Pharma Mar, S. A.
    Inventors: José Fernando Reyes Benítez, Gloria Crespo Sueiro, Rogelio Fernández Rodríguez, Andrés Francesch Solloso, María del Carmen Cuevas Marchante
  • Anticancer Compounds
    Publication number: 20110105409
    Abstract: Anticancer compounds of general formula I: wherein R1-R11 take permitted meanings for use in the treatment of cancer.
    Type: Application
    Filed: July 16, 2009
    Publication date: May 5, 2011
    Applicant: PHARMA MAR, S.A.
    Inventors: Raquel Rodríguez Acebes, Rogelio Fernández Rodríguez, José Fernando Reyes Benítez, Ma Jesús Martín López, Isabel Marco Martínez, Isabel Digón Juárez, Maria del Carmen Cuevas Marchante, Andrés Francesch Solloso
  • Antitumoral Compounds
    Publication number: 20110034549
    Abstract: A compound of general formula (I) wherein A, Y, W, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
    Type: Application
    Filed: December 19, 2008
    Publication date: February 10, 2011
    Applicant: PHARMA MAR, S.A.
    Inventors: Alberto Rodriguez Vicente, María Garranzo García-Ibarrola, Carmen Murcia Pérez, Francisco Sánchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digón Juárez